We are live on ! Find out more
MAM

Marquette Asset Management Portfolio holdings

AUM $779M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.51%
5 Year Est. Return
+57.16%
10 Year Est. Return
+244.82%
AUM
$338M
AUM Growth
+$18.3M
Cap. Flow
-$921K
Cap. Flow %
-0.27%
Top 10 Hldgs %
74.1%
Holding
294
New
44
Increased
31
Reduced
59
Closed
77
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVEM icon
126
Avantis Emerging Markets Equity ETF
AVEM
$26.4B
$78.8K 0.02%
1,562
+209
+15% +$10.2K
KRON
127
DELISTED
Kronos Bio
KRON
$78.7K 0.02%
+48,557
New +$112K
AMZN icon
128
Amazon
AMZN
$2.98T
$77.3K 0.02%
920
-880
-49% -$86.9K
LUMO
129
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$75.9K 0.02%
21,020
+7,705
+58% +$50.4K
SPRB
130
Spruce Biosciences
SPRB
$129M
$75K 0.02%
911
+56
+7% +$4.69K
VTV icon
131
Vanguard Morningstar Value ETF
VTV
$191B
$75K 0.02%
+534
New +$73.6K
OMIC
132
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$73.4K 0.02%
+1,217
New +$81.6K
AFL icon
133
Aflac
AFL
$63.1B
$71.9K 0.02%
1,000
CAT icon
134
Caterpillar
CAT
$396B
$71.9K 0.02%
300
SVRA icon
135
Savara
SVRA
$1.21B
$71.7K 0.02%
46,249
STSA
136
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$70.7K 0.02%
+78,551
New +$228K
ADVM
137
DELISTED
Adverum Biotechnologies
ADVM
$70.3K 0.02%
12,139
+2,448
+25% +$18.6K
IVV icon
138
iShares Core S&P 500 ETF
IVV
$901B
$69.5K 0.02%
181
-3
-2% -$1.16K
VEA icon
139
Vanguard FTSE Developed Markets ETF
VEA
$237B
$69.3K 0.02%
1,651
+1,524
+1,200% +$61.7K
HTLF
140
DELISTED
Heartland Financial USA, Inc.
HTLF
$69K 0.02%
1,479
UHS icon
141
Universal Health Services
UHS
$10.2B
$68.8K 0.02%
488
AMGN icon
142
Amgen
AMGN
$219B
$68.5K 0.02%
261
MHD icon
143
BlackRock MuniHoldings Fund
MHD
$608M
$66.8K 0.02%
5,502
-1,685
-23% -$19.3K
KO icon
144
Coca-Cola
KO
$373B
$64.6K 0.02%
1,016
+816
+408% +$49.3K
SERA icon
145
Sera Prognostics
SERA
$78.3M
$63.5K 0.02%
+50,389
New +$71.2K
BDTX icon
146
Black Diamond Therapeutics
BDTX
$113M
$61.9K 0.02%
+34,400
New +$62K
KMB icon
147
Kimberly-Clark
KMB
$36.1B
$57.4K 0.02%
423
APG icon
148
APi Group
APG
$18.2B
$56.4K 0.02%
4,500
JPM icon
149
JPMorgan Chase
JPM
$944B
$53.6K 0.02%
400
-823
-67% -$104K
AMAT icon
150
Applied Materials
AMAT
$430B
$52.6K 0.02%
540
-115
-18% -$11K

Similar funds

Marquette Asset Management's Q4 2022 Portfolio in Review

As of Q4 2022, Marquette Asset Management held 294 positions worth $338M, up 5.7% from $320M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

Marquette Asset Management's Q4 2022 filing shows 44 new, 31 increased, 59 reduced and 77 closed positions. Its largest new stake was Victory Portfolios II VictoryShares Short-Term Bond ETF: 564,342 shares worth $27.4M. The largest sale was Vanguard Short-Term Bond ETF, an estimated $20.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 1.8% of assets, up from 1.7% a quarter earlier, followed by Healthcare and Technology.

  • Marquette Asset Management's largest Q4 2022 buy was Victory Portfolios II VictoryShares Short-Term Bond ETF: 564,342 shares worth $27.4M.
  • Marquette Asset Management added most to First Trust Dow Jones Select MicroCap Index Fund in Q4 2022, an estimated $4.6M increase.
  • Marquette Asset Management's biggest Q4 2022 reduction was Vanguard Short-Term Bond ETF, cutting an estimated $20.6M.
  • Marquette Asset Management fully exited Churchill Capital Corp V in Q4 2022, selling an estimated $231K.
  • Marquette Asset Management's ten largest holdings make up 74% of its $338M portfolio in Q4 2022.
  • Marquette Asset Management opened 44 new positions and closed 77 in Q4 2022.
  • Marquette Asset Management's portfolio value rose 5.7% quarter-over-quarter to $338M.

Based on Marquette Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.